Non-invasive biosensors are novel diagnosis devices, which do not require any invasive procedure for detection of any substance or disease. This technology uses sweat, tears, or saliva for diagnostic purpose. Glucose monitoring and blood analytes monitor have become available in the market, which uses non-invasive biosensors. Moreover, there are many non-invasive biosensors under development and under clinical trial for new applications such as cancer and blood alcohol concentration detection.
Market Dynamics
Increasing approval and launches of novel non-invasive biosensors is expected to boost growth of global non-invasive biosensors market in the near future. For instance, in 2016, Nemaura Medical, Inc. received CE approval in the European Union for its latest sugarBEAT, a minimally invasive wireless continuous glucose monitor. Moreover, in 2013, Integrity Applications Inc. received CE marking for its new GlucoTrack DF-F device, a non-invasive blood glucose monitoring device. Increasing research and development activities for developing novel non-invasive biosensors is also expected to drive growth of market in the near future. For instance, in 2017, Mclean Hospital announced that LabPatch-alcohol, its non-invasive skin patch that detects blood alcohol concentration, is in clinical trial. LabPatch-alcohol is in early Phase 1 stage of clinical trial. Furthermore, increasing prevalence of diabetes is also expected to increase demand for non-invasive biosensors for diagnosis. According to the World Health Organization (WHO), 2014, around 8.5% of adults aged 18 and above accounting for 422 million adults were suffering from diabetes worldwide.
Key features of the study:
- This report provides in-depth analysis of non-invasive biosensors market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global non-invasive biosensors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc., OrSense, Medtronic Plc, GE Healthcare, Philips Healthcare, Akers Biosciences, Inc. and Abbott Laboratories
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global non-invasive biosensors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the non-invasive biosensors market
Detailed Segmentation:
- Global Non-Invasive Biosensors Market, By Technology :
- Optical
- Transdermal
- Thermal
- Others
- Global Non-Invasive Biosensors Market, By Product Type:
- Glucose Monitors
- Blood Analytes Monitors
- Breathalyzers
- Others
- Global Non-Invasive Biosensors Market, By End User:
- Hospital
- Diagnostic Lab
- Homecare Settings
- Others
- Global Non-Invasive Biosensors Market, By Geography:
- North America
- By Technology :
- Optical
- Transdermal
- Thermal
- Others
- By Product Type
- Glucose Monitors
- Blood Analytes Monitors
- Breathalyzers
- Others
- By End User:
- Hospital
- Diagnostic Lab
- Homecare Settings
- Others
- By Country:
- Europe
- By Technology :
- Optical
- Transdermal
- Thermal
- Others
- By Product Type
- Glucose Monitors
- Blood Analytes Monitors
- Breathalyzers
- Others
- By End User:
- Hospital
- Diagnostic Lab
- Homecare Settings
- Others
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Technology :
- Optical
- Transdermal
- Thermal
- Others
- By Product Type
- Glucose Monitors
- Blood Analytes Monitors
- Breathalyzers
- Others
- By End User:
- Hospital
- Diagnostic Lab
- Homecare Settings
- Others
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Technology :
- Optical
- Transdermal
- Thermal
- Others
- By Product Type
- Glucose Monitors
- Blood Analytes Monitors
- Breathalyzers
- Others
- By End User:
- Hospital
- Diagnostic Lab
- Homecare Settings
- Others
- By Country:
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- By Technology :
- Optical
- Transdermal
- Thermal
- Others
- By Product Type
- Glucose Monitors
- Blood Analytes Monitors
- Breathalyzers
- Others
- By End User:
- Hospital
- Diagnostic Lab
- Homecare Settings
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Technology :
- Optical
- Transdermal
- Thermal
- Others
- By Product Type
- Glucose Monitors
- Blood Analytes Monitors
- Breathalyzers
- Others
- By End User:
- Hospital
- Diagnostic Lab
- Homecare Settings
- Others
- By Country:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Nemaura Medical, Inc.*
- Company Overview
- Product Portfolio
- Recent Developments
- Financial Performance
- Key Strategies
- MediWise Ltd.
- Integrity Applications Inc.
- OrSense
- Medtronic Plc
- GE Healthcare
- Philips Healthcare
- Akers Biosciences, Inc.
- Abbott Laboratories
“*” marked represents similar segmentation in other categories in the respective section.
